Krystal Biotech, Inc.
DE ˙ DB ˙ US5011471027
257,90 € ↓ −1,10 (−0,42%)
2026-06-04
DELAT PRIS
SecurityDE:4KB / Krystal Biotech, Inc.
InstitutionStrs Ohio
Latest Disclosed Ownership6,400 shares
Latest Disclosed Value $ 1,653,248
Strs Ohio reports 1.54% decrease in ownership of 4KB / Krystal Biotech, Inc.

On April 24, 2026 - Strs Ohio filed a 13F-HR form disclosing ownership of 6,400 shares of Krystal Biotech, Inc. (DE:4KB) valued at $1,377,280 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 6,500 shares of Krystal Biotech, Inc.. This represents a change in shares of -1.54% during the quarter. The current value of the position is $1,650,560 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F KRYSTAL BIOTECH COM_STK 501147102 6,400 -100 -1.54 1,653 3.18 0.0066
2026-02-02 2025-12-31 13F KRYSTAL BIOTECH COM_STK 501147102 6,500 -900 -12.16 1,603 22.66 0.0060
2025-10-30 2025-09-30 13F KRYSTAL BIOTECH COM_STK 501147102 7,400 0 0.00 1,306 28.42 0.0048
2025-08-04 2025-06-30 13F KRYSTAL BIOTECH COM_STK 501147102 7,400 500 7.25 1,017 -18.25 0.0038
2025-05-28 2025-03-31 13F KRYSTAL BIOTECH COM_STK 501147102 6,900 -400 -5.48 1,244 8.84 0.0052
2025-05-28 2024-12-31 13F KRYSTAL BIOTECH COM_STK 501147102 7,300 2,300 46.00 1,144 25.60 0.0045
2024-11-01 2024-09-30 13F KRYSTAL BIOTECH COM_STK 501147102 5,000 800 19.05 910 18.03 0.0035
2024-08-05 2024-06-30 13F KRYSTAL BIOTECH COM_STK 501147102 4,200 2,000 90.91 771 0.0030
2024-05-13 2024-03-31 13F KRYSTAL BIOTECH COM_STK 501147102 2,200 -3,400 -60.71 0 0.0016
2024-01-30 2023-12-31 13F KRYSTAL BIOTECH COM 501147102 5,600 -800 -12.50 1 0.0029
2023-10-26 2023-09-30 13F/A-1 KRYSTAL BIOTECH COM 501147102 6,400 3,500 120.69 1 0.0033
2023-10-26 2023-09-30 13F KRYSTAL BIOTECH COM 501147102 6,400 3,500 1 0.0033
2023-07-31 2023-06-30 13F KRYSTAL BIOTECH COM 501147102 2,900 1,600 123.08 0 0.0014
2023-08-02 2023-03-31 13F/A-2 KRYSTAL BIOTECH COM 501147102 1,300 -2,800 -68.29 0 0.0005
2023-08-02 2023-03-31 13F/A-1 KRYSTAL BIOTECH COM 501147102 1,300 -2,800 0 0.0005
2023-04-27 2023-03-31 13F KRYSTAL BIOTECH COM 501147102 1,300 -2,800 0 0.0005
2023-01-26 2022-12-31 13F KRYSTAL BIOTECH COM 501147102 4,100 0 0.00 0 -100.00 0.0015
2022-10-27 2022-09-30 13F KRYSTAL BIOTECH COM 501147102 4,100 0 0.00 285 5.95 0.0014
2022-07-25 2022-06-30 13F KRYSTAL BIOTECH COM 501147102 4,100 200 5.13 269 3.86 0.0012
2022-04-21 2022-03-31 13F KRYSTAL BIOTECH COM 501147102 3,900 0 0.00 259 -4.78 0.0009
2022-01-24 2021-12-31 13F KRYSTAL BIOTECH COM 501147102 3,900 0 0.00 272 33.99 0.0009
2021-10-22 2021-09-30 13F KRYSTAL BIOTECH COM 501147102 3,900 0 0.00 203 -23.40 0.0008
2021-07-26 2021-06-30 13F KRYSTAL BIOTECH COM 501147102 3,900 3,900 265 0.0010
2020-12-14 2020-09-30 13F KRYSTAL BIOTECH COM 501147102 0 -2,300 -100.00 0 -100.00
2020-07-23 2020-06-30 13F KRYSTAL BIOTECH COM 501147102 2,300 0 0.00 95 -4.04 0.0004
2020-04-23 2020-03-31 13F KRYSTAL BIOTECH COM 501147102 2,300 0 0.00 99 -22.05 0.0005
2020-01-24 2019-12-31 13F KRYSTAL BIOTECH COM 501147102 2,300 0 0.00 127 60.76 0.0005
2019-10-21 2019-09-30 13F/A-1 KRYSTAL BIOTECH COM 501147102 2,300 0 0.00 79 -14.13 0.0003
2019-10-21 2019-09-30 13F KRYSTAL BIOTECH COM 501147102 2,300 0 79 349.6584
2019-07-25 2019-06-30 13F KRYSTAL BIOTECH COM 501147102 2,300 2,300 92 0.0004
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.